Ultima-Selank 10mg

MANUFACTURER Ultima Pharmaceuticals - USA
WAREHOUSE USA Warehouse 5
SUBSTANCE Selank

For security reasons, products are shipped without brand labels.

The rapid advancements in biotechnology have opened the door to exploration of innovative biologically active substances, particularly in the realm of "cognitive enhancers" or "nootropics." One remarkable compound in this space is Selank, formerly known as "TP-7." This synthetic peptide?an artificially designed small protein?has gained attention for its potential benefits.

Promoted as a safe ?anti-anxiety? agent, Selank is also believed to enhance cognitive function and increase energy levels without the risk of side effects or addiction. Its molecular structure is significantly smaller than that of most natural proteins, having been developed through collaborative efforts at the Institute of Molecular Genetics (part of the Russian Academy of Sciences) alongside the V.V. Zakusov Research Institute of Pharmacology, in conjunction with its counterpart, Semax.

Selank's formulation integrates the sequence of a naturally occurring peptide called tuftsin with another sequence that enhances its stability. Tuftsin is a vital component of the natural antibody IgG.

Both tuftsin and Selank have demonstrated the ability to reduce anxiety and increase serotonin levels in animal studies, with Selank showing slightly greater efficacy.

In Russia, Selank is approved for treating generalized anxiety disorder (GAD) and is recognized for its nootropic properties. However, it has yet to receive FDA approval for any medical conditions. Nevertheless, Selank remains accessible in various countries, often marketed as a ?nutritional supplement.?

Selank Mechanism of Action

While the precise mechanisms of Selank's action are not fully understood, it is believed to stabilize enkephalins in the bloodstream?natural peptides that help mitigate stress responses. A study on mice, however, did not confirm enkephalin stabilization post-Selank administration, nor did it observe significant anti-anxiety effects.

Research suggests that Selank may interact with GABA receptors, as many compounds binding to these receptors often induce sedative effects. One study indicated that Selank increased activity in GABA-dependent inhibitory neurons, correlating with reduced overall brain activity, which aligns with a sedative effect.

Additionally, some studies hint at an increase in BDNF, a crucial neurotrophic factor linked to learning and memory, potentially explaining some of Selank's purported cognitive benefits.

Evidence also suggests that Selank may influence neurotransmitter levels, including norepinephrine, dopamine, and serotonin in mice?neurotransmitters associated with motivation, focus, and pleasure. However, findings are mixed; one study indicated Selank may raise norepinephrine levels while lowering dopamine and serotonin, while another found increases in both norepinephrine and dopamine without affecting serotonin. Thus, the exact effects and mechanisms of Selank remain somewhat ambiguous.

Potential Uses of Selank

Anxiety

A preliminary clinical study with 62 participants found that Selank significantly reduced anxiety symptoms, particularly in individuals with existing anxiety disorders. In another trial involving 60 patients experiencing anxiety and phobias, similar benefits were noted, with effects lasting up to a week post-treatment.

Furthermore, in a study involving 70 anxiety patients, Selank enhanced the effects of phenazepam (a restricted anti-anxiety medication in the U.S.) while reportedly mitigating negative side effects like drowsiness and memory loss. Animal studies also indicated that Selank could effectively decrease anxiety in mice, with the most anxious subjects showing the greatest behavioral improvement. Despite limited evidence, these findings suggest Selank may offer relief from anxiety, although further research is necessary to confirm its effectiveness and safety in humans. Always consult your healthcare provider before considering Selank, and never substitute it for prescribed treatments without professional advice.

Memory

In one study, Selank was found to stabilize memory traces in rats, potentially enhancing memory retention over a 30-day period. However, the methods used to measure these effects remain unclear, as memory traces do not have identifiable locations in the brain. Another study suggested Selank might aid memory preservation in monkeys, but comprehensive human studies are lacking to assess its effects on healthy individuals, leading to caution regarding its safety for such users.

Recovery from Brain Damage

A study revealed that Selank administration in rats with toxin-induced brain damage restored their brain activity to normal levels.

Depression

Selank has shown promise in reducing symptoms of depression, particularly noted in a forced swimming test with mice, where it proved more effective at lower doses than higher ones.

Antioxidant Activity in the Liver

Initial animal studies indicated that Selank injections boosted antioxidant levels in the livers of stressed mice.

Blood Circulation

In a study with sedated cats, Selank reduced blood pressure by approximately 30% for up to 3 minutes and increased cerebral blood flow by about 24% for up to 10 minutes. While these preliminary observations suggest potential short-term cardiovascular effects, the brief duration raises questions about clinical significance, particularly as these findings are limited to animals.

Alcohol Withdrawal

Given that anxiety is a common symptom of alcohol withdrawal, a study in which rats underwent a 48-hour withdrawal period post-high alcohol intake revealed reduced anxiety following Selank treatment.

Weight Management and Cholesterol Reduction

An animal study indicated that rats on a high-fat diet experienced 35% less weight gain while treated with Selank. Additionally, their total cholesterol levels reportedly decreased by over 58%, and blood glucose levels dropped by 23.5%.

Cancer

In an animal model, mice with breast cancer showed slower tumor growth and longer survival rates when treated daily with Selank. However, these findings do not imply that Selank is suitable for cancer therapy; substantial further research is required to determine any medicinal value for cancer treatment, and it should never replace conventional methods.

Spleen Inflammation

After Selank treatment, increases in several inflammatory response genes were noted in the spleens of mice, suggesting potential protective benefits against the effects of inflammation.

Ulcer Mitigation

Selank has been shown to reduce the area of stomach ulcers in animal studies, with some researchers hypothesizing this effect may be due to increased lymph flow to the stomach. More comprehensive human studies are needed to validate these findings and uncover the underlying mechanisms.

Immune Function

Selank was found to elevate IL-6 levels in the blood cells of depressed patients, an inflammatory protein that may aid in fighting infections. Additionally, one cell-based study indicated that Selank might stimulate the release of interferons, known for their anti-viral properties. However, a mouse study infected with a virus found no anti-viral benefits from Selank treatment, raising doubts about this potential application.